Safety aspects of aprotinin therapy in cardiac surgery patients.

about

The impact of administration of tranexamic acid in reducing the use of red blood cells and other blood products in cardiac surgery Antifibrinolytic therapy: evidence, bias, confounding (and politics!).

P2860

Q28200360-11A358DE-1961-45E4-AEA5-56E7C9859354 Q37092164-2CDAA2C9-8C3B-4EB4-A2E3-18BC6F10BA95

P2860

Safety aspects of aprotinin therapy in cardiac surgery patients.

Item

http://www.wikidata.org/entity/Q36506820

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Safety aspects of aprotinin therapy in cardiac surgery patients.

@ast

Safety aspects of aprotinin therapy in cardiac surgery patients.

@en

type

Item

label

Safety aspects of aprotinin therapy in cardiac surgery patients.

@ast

Safety aspects of aprotinin therapy in cardiac surgery patients.

@en

prefLabel

Safety aspects of aprotinin therapy in cardiac surgery patients.

@ast

Safety aspects of aprotinin therapy in cardiac surgery patients.

@en

P1476

Safety aspects of aprotinin therapy in cardiac surgery patients.

@en

P2093

Asha Chhatwani

http://www.w3.org/2001/XMLSchema#string

David Royston

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation

Comparison of two strategies for the management of antiplatelet therapy during urgent surgery

Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting

Adverse reactions to anticoagulants and to antiplatelet drugs recorded by the German spontaneous reporting system

Aspirin and mortality from coronary bypass surgery

Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting

The Society of Thoracic Surgeons practice guideline series: aspirin and other antiplatelet agents during operative coronary revascularization (executive summary)

Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials

Aprotinin in major orthopedic surgery: a systematic review of randomized controlled trials

The risk associated with aprotinin in cardiac surgery

P304

539-552

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1517/14740338.5.4.539

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16774492

http://www.w3.org/2001/XMLSchema#string

P921

cardiac surgery

Safety aspects of aprotinin therapy in cardiac surgery patients.

about

P2860

P2860

Safety aspects of aprotinin therapy in cardiac surgery patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921